SCHEMBL2883395

SCHEMBL2883395

COCCOC(=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28885388 0.98 TSHR (0.41)
SCHEMBL20801668 0.93 TSHR (0.38)
SCHEMBL13713461 0.93 TSHR (0.38)
SCHEMBL26756098 0.93 TSHR (0.38)
SCHEMBL2593332 0.93 TSHR (0.38)
Hydrochloric Acid SCHEMBL28078980 0.91 TSHR (0.37)
SCHEMBL3121478 0.87 GLRA1 (0.39)
SCHEMBL4277520 0.86 HTR2C (0.43)
Hydrochloric Acid SCHEMBL7675204 0.84 HTR2C (0.38)
Hydrochloric Acid SCHEMBL7675200 0.84 HTR2C (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2010527270-A 2010-08-12 JP claimed
EP-2155276-A2 MEDICAL DEVICES HAVING ANTIFOULING CHARACTER Boston Scientific Scimed, Inc. (US) 2010-02-24 EP claimed
WO-2008144392-A2 MEDICAL DEVICES HAVING ANTIFOULING CHARACTER BOSTON SCIENTIFIC SCIMED, INC. (US) 2008-11-27 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
US-20230407285-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF DOGMA THERAPEUTICS, INC. 2023-12-21 US disclosed
CN-116194084-A Cleavable lipid compounds, compositions containing the same and uses thereof 赛诺菲巴斯德有限公司 2023-05-30 CN disclosed
US-11603523-B2 PCSK9 inhibitors and methods of use thereof ASTRAZENECA AB (SE) 2023-03-14 US disclosed
CN-115160380-A Compound capable of controlling CO release rate and preparation method thereof 西安交通大学医学院第一附属医院 2022-10-11 CN disclosed
US-20220220122-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF ASTRAZENECA AB (SE) 2022-07-14 US disclosed
EP-3642198-B1 SMALL MOLECULE MODULATORS OF HUMAN STING CURADEV PHARMA LTD (GB) 2022-03-16 EP disclosed
EP-3911648-A2 PCSK9 INHIBITORS AND METHODS OF USE THEREOF Astrazeneca AB (SE) 2021-11-24 EP disclosed
EP-3911640-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF Astrazeneca AB (SE) 2021-11-24 EP disclosed
EP-1814976-A2 PEPTIDOMIMETIC POLYMERS FOR ANTIFOULING SURFACES Northwestern University (US) 2007-08-08 EP disclosed
WO-2006055531-A2 PEPTIDOMIMETIC POLYMERS FOR ANTIFOULING SURFACES NORTHWESTERN UNIVERSITY (US) 2006-05-26 WO disclosed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed
US-5521145-A Iminothiazoline derivatives and herbicides containing them as active ingredients SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1996-05-28 US disclosed
EP-0683160-A1 Iminothiazoline derivatives and herbicides containing them as active ingredients SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-11-22 EP disclosed
EP-0137145-B1 NEW CAMPTOTHECIN DERIVATIVES AND PROCESS FOR PREPARING SAME KABUSHIKI KAISHA YAKULT HONSHA (JP) 1988-04-27 EP disclosed
US-4604463-A ANTITUMOR AGENTS KABUSHIKI KAISHA YAKULT HONSHA (JP) 1986-08-05 US disclosed
EP-0137145-A1 New camptothecin derivatives and process for preparing same KABUSHIKI KAISHA YAKULT HONSHA (JP) 1985-04-17 EP disclosed